The company
Owlet, Inc.
OWLT · NYSE
OWLT stood above a rising 150-day average in 19 of the last 52 weekly readings, and has been out of that trend for the last 33 weeks. It is 21.9% below that average now. Life Science Tools & Research Services: 52% of its 79 stocks in an uptrend (+4 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 33
- Industry in uptrend
- 52% +4 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $664K
- Officials’ trades on record
- 0
- Institutions holding
- 53 (-8)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 19 of 52 weeks.
Life-science tools: About half its stocks are in an uptrend and the share has been climbing. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Amanda CrawfordChief Financial Officer | sold | 6,892at $11.50 | 27 Feb 2026filed 30 Apr 2026 |
| Jonathan HarrisOther | sold | 12,676at $11.50 | 26 Feb 2026filed 30 Apr 2026 |
| Jonathan HarrisOther | sold | 3,540at $10.65 | 17 Feb 2026filed 30 Apr 2026 |
| Jonathan HarrisPresident and CEO | sold | 2,311at $13.33 | 20 Jan 2026filed 22 Jan 2026 |
| Amanda CrawfordChief Financial Officer | sold | 183at $13.33 | 20 Jan 2026filed 22 Jan 2026 |
| Jonathan HarrisOther | sold | 3,423at $10.49 | 17 Nov 2025filed 30 Apr 2026 |
| Jonathan HarrisOther | sold | 1,851at $8.75 | 16 Oct 2025filed 30 Apr 2026 |
| Amanda CrawfordChief Financial Officer | sold | 149at $8.75 | 16 Oct 2025filed 30 Apr 2026 |
| Kurt WorkmanPresident & CEO | sold | 49,056at $8.46 | 3 Oct 2025filed 30 Apr 2026 |
| Kurt WorkmanPresident & CEO | sold | 1,014at $7.25 | 17 Sep 2025filed 30 Apr 2026 |
| Amanda CrawfordChief Financial Officer | sold | 4,225at $7.06 | 10 Sep 2025filed 30 Apr 2026 |
| Jonathan HarrisOther | sold | 3,315at $7.72 | 19 Aug 2025filed 30 Apr 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| ECLIPSE OPERATIONS, LLCunchanged · filed 7 Aug 2026 | 7,700,835$44.2M | 00.0% |
| Granahan Investment Management, LLCadded · filed 14 Aug 2026 | 1,595,419$9.2M | +408,764+34.4% |
| CANNELL CAPITAL LLCadded · filed 18 Aug 2026 | 1,234,053$7.1M | +235,888+23.6% |
| AWM Investment Company, Inc.reduced · filed 14 Aug 2026 | 1,225,353$7.0M | -753,117−38.1% |
| VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026 | 801,718$4.6M | +20,197+2.6% |
| AMERIPRISE FINANCIAL INCreduced · filed 14 Aug 2026 | 512,655$2.9M | -723,406−58.5% |
| JACOBS LEVY EQUITY MANAGEMENT, INCadded · filed 14 Aug 2026 | 330,824$1.9M | +259,058+361.0% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 329,883$1.9M | +7,360+2.3% |
| Meros Investment Management, LPadded · filed 14 Aug 2026 | 327,112$1.9M | +189,665+138.0% |
| CITADEL ADVISORS LLCnew · filed 14 Aug 2026 | 251,137$1.4M | +251,137 |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.